Title : Real-world efficacy and safety of nebivolol in Korean patients with hypertension from the BENEFIT KOREA study.

Pub. Date : 2020 Mar

PMID : 31693535






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The reductions of SBP and DBP were notably greater when nebivolol was used as monotherapy in de novo patients (P < 0.0001) and as add-on therapy to existing antihypertensives (angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors and calcium channel blockers; P < 0.0001). Calcium selenium binding protein 1 Homo sapiens